These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. High-grade vulvar intraepithelial neoplasia: comprehensive characterization and long-term vulvar carcinoma risk. Thuijs NB; van Beurden M; Duin S; Heideman DAM; Berkhof J; Steenbergen RDM; Bleeker MCG Histopathology; 2024 Jan; 84(2):301-314. PubMed ID: 37726173 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome. Tessier-Cloutier B; Pors J; Thompson E; Ho J; Prentice L; McConechy M; Aguirre-Hernandez R; Miller R; Leung S; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Hoang LN Mod Pathol; 2021 Feb; 34(2):508-518. PubMed ID: 32792599 [TBL] [Abstract][Full Text] [Related]
12. HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva. Parra-Herran C; Nucci MR; Singh N; Rakislova N; Howitt BE; Hoang L; Gilks CB; Bosse T; Watkins JC Mod Pathol; 2022 Oct; 35(10):1317-1326. PubMed ID: 35437330 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Santos M; Montagut C; Mellado B; García A; Ramón y Cajal S; Cardesa A; Puig-Tintoré LM; Ordi J Int J Gynecol Pathol; 2004 Jul; 23(3):206-14. PubMed ID: 15213596 [TBL] [Abstract][Full Text] [Related]
14. Somatic Mutation Profiling in Premalignant Lesions of Vulvar Squamous Cell Carcinoma. Zięba S; Pouwer AW; Kowalik A; Zalewski K; Rusetska N; Bakuła-Zalewska E; Kopczyński J; Pijnenborg JMA; de Hullu JA; Kowalewska M Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664330 [TBL] [Abstract][Full Text] [Related]
16. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas. Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483 [TBL] [Abstract][Full Text] [Related]
17. p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases. Cheng AS; Karnezis AN; Jordan S; Singh N; McAlpine JN; Gilks CB Int J Gynecol Pathol; 2016 Jul; 35(4):385-93. PubMed ID: 26630231 [TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus-Independent Squamous Lesions of the Vulva. Watkins JC Surg Pathol Clin; 2019 Jun; 12(2):249-261. PubMed ID: 31097103 [TBL] [Abstract][Full Text] [Related]
19. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Del Pino M; Rodriguez-Carunchio L; Ordi J Histopathology; 2013 Jan; 62(1):161-75. PubMed ID: 23190170 [TBL] [Abstract][Full Text] [Related]
20. GATA3 immunohistochemistry as a diagnostic adjunct for differentiated vulvar intraepithelial neoplasia: utility and limitations. Zare SY; Fard EV; Fadare O Hum Pathol; 2023 Sep; 139():55-64. PubMed ID: 37454993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]